Abstract
摘要
相似文献
1
IDSA '98 highlights.
HIV Hotline. 1998 Dec;8(5-6):1, 6-7, 9.
2
[Lipodystrophy and 'buffalo hump' during treatment with HIV protease inhibitors].[HIV蛋白酶抑制剂治疗期间的脂肪代谢障碍和“水牛背”]
Ned Tijdschr Geneeskd. 1998 Dec 26;142(52):2856-60.
3
The HIV-associated lipodystrophy syndrome: research, results, yet more questions.
AIDS. 2001 Jan 26;15(2):271-3. doi: 10.1097/00002030-200101260-00019.
4
Fat, sugar and drugs on the French Riviera.
GMHC Treat Issues. 1999 Mar;13(3):9-11.
5
6
Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection.人类免疫缺陷病毒感染中的脂肪营养不良、胰岛素抵抗、糖尿病、血脂异常和心血管疾病。
South Med J. 2003 Feb;96(2):180-8; quiz 189. doi: 10.1097/01.SMJ.0000051731.69719.2E.
7
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial.在 HIV-1 病毒学稳定的患者中，使用阿扎那韦-利托那韦联合拉米夫定进行双重治疗与使用阿扎那韦-利托那韦联合两种核苷（酸）逆转录酶抑制剂进行三重治疗的疗效比较（SALT）：一项随机、开放标签、非劣效性试验的 48 周结果。
Lancet Infect Dis. 2015 Jul;15(7):775-84. doi: 10.1016/S1473-3099(15)00097-3. Epub 2015 Jun 7.
8
Lipodystrophy in patients naive to HIV protease inhibitors.
AIDS. 1999 Apr 16;13(6):735-7. doi: 10.1097/00002030-199904160-00020.
9
Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection.
AIDS Res Hum Retroviruses. 2004 Jun;20(6):589-94. doi: 10.1089/0889222041217374.
10
Metabolic abnormalities in patients with HIV infection.
J Int Assoc Physicians AIDS Care (Chic). 2003 Apr-Jun;2(2):66-74. doi: 10.1177/154510970300200203.
Zotero 插件